List of Excipients in API VALACYCLOVIR HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing VALACYCLOVIR HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | CARNAUBA WAX | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | CROSPOVIDONE | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | FD&C BLUE NO. 2 | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | HYPROMELLOSE | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | MAGNESIUM STEARATE | |
| GlaxoSmithKline LLC | VALTREX | valacyclovir hydrochloride | 0173-0933 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing VALACYCLOVIR HYDROCHLORIDE
Detailed excipient profiles for VALACYCLOVIR HYDROCHLORIDE
Excipient focus: ALUMINUM OXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | valacyclovir hydrochloride | 53808-0635 |
| MedVantx Inc | valacyclovir hydrochloride | 66116-516 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing ALUMINUM OXIDE
Excipient focus: CARNAUBA WAX
VALACYCLOVIR HYDROCHLORIDE drug variants containing CARNAUBA WAX
VALACYCLOVIR HYDROCHLORIDE drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VALACYCLOVIR HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | valacyclovir hydrochloride | 54868-3804 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
VALACYCLOVIR HYDROCHLORIDE drug variants containing CROSCARMELLOSE SODIUM
VALACYCLOVIR HYDROCHLORIDE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
VALACYCLOVIR HYDROCHLORIDE drug variants containing CROSPOVIDONE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
VALACYCLOVIR HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
VALACYCLOVIR HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional Inc | valacyclovir hydrochloride | 51079-093 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 71335-1341 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional Inc | valacyclovir hydrochloride | 51079-093 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 71335-1341 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROGENATED CASTOR OIL
VALACYCLOVIR HYDROCHLORIDE drug variants containing HYDROGENATED CASTOR OIL
VALACYCLOVIR HYDROCHLORIDE drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYPROMELLOSE
VALACYCLOVIR HYDROCHLORIDE drug variants containing HYPROMELLOSE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
VALACYCLOVIR HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
VALACYCLOVIR HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
VALACYCLOVIR HYDROCHLORIDE drug variants containing HYPROMELLOSES
VALACYCLOVIR HYDROCHLORIDE drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
VALACYCLOVIR HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE
VALACYCLOVIR HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | valacyclovir hydrochloride | 43353-883 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE
Excipient focus: POLYETHYLENE GLYCOL
VALACYCLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
VALACYCLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
VALACYCLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Ohm Laboratories Inc | valacyclovir hydrochloride | 51660-904 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOLS
VALACYCLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | valacyclovir hydrochloride | 10544-937 |
| Physicians Total Care Inc | valacyclovir hydrochloride | 54868-3804 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 63629-3982 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
VALACYCLOVIR HYDROCHLORIDE drug variants containing POLYSORBATE 80
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional Inc | valacyclovir hydrochloride | 51079-093 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 71335-1341 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
VALACYCLOVIR HYDROCHLORIDE drug variants containing POVIDONE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: POVIDONE K90
VALACYCLOVIR HYDROCHLORIDE drug variants containing POVIDONE K90
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POVIDONE K90
Excipient focus: POVIDONES
VALACYCLOVIR HYDROCHLORIDE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Ohm Laboratories Inc | valacyclovir hydrochloride | 51660-904 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 63629-3982 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POVIDONES
Excipient focus: POWDERED CELLULOSE
VALACYCLOVIR HYDROCHLORIDE drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | valacyclovir hydrochloride | 53808-0635 |
| MedVantx Inc | valacyclovir hydrochloride | 66116-516 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing POWDERED CELLULOSE
Excipient focus: PROPYLENE GLYCOL
VALACYCLOVIR HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional Inc | valacyclovir hydrochloride | 51079-093 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 71335-1341 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
VALACYCLOVIR HYDROCHLORIDE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional Inc | valacyclovir hydrochloride | 51079-093 |
| Bryant Ranch Prepack | valacyclovir hydrochloride | 71335-1341 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants containing SILICON DIOXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
VALACYCLOVIR HYDROCHLORIDE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | valacyclovir hydrochloride | 53808-0635 |
| MedVantx Inc | valacyclovir hydrochloride | 66116-516 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
VALACYCLOVIR HYDROCHLORIDE drug variants containing STARCH, CORN
VALACYCLOVIR HYDROCHLORIDE drug variants not containing STARCH, CORN
Excipient focus: TALC
VALACYCLOVIR HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | valacyclovir hydrochloride | 53217-054 |
| Wockhardt Limited | valacyclovir hydrochloride | 55648-152 |
| Wockhardt USA LLC | valacyclovir hydrochloride | 64679-152 |
| >Company | >Ingredient | >NDC |
VALACYCLOVIR HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
VALACYCLOVIR HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
